Literature DB >> 27134271

Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual Meeting.

Ana-Maria Orbai1, Philip J Mease1, Maarten de Wit1, Umut Kalyoncu1, Willemina Campbell1, William Tillett1, Lihi Eder1, Musaab Elmamoun1, Oliver FitzGerald1, Dafna D Gladman1, Niti Goel1, Laure Gossec1, Chris A Lindsay1, Ingrid Steinkoenig1, Philip S Helliwell1, Neil J McHugh1, Vibeke Strand1, Alexis Ogdie1.   

Abstract

The GRAPPA-OMERACT psoriatic arthritis (PsA) working group is in the process of updating the PsA core domain set to improve and standardize the measurement of PsA outcomes. Work streams comprise literature reviews of domains and outcome measurement instruments, an international qualitative research project with PsA patients to generate domains important to patients, outcome measurement instrument assessment, conduct of domain consensus panels with patients and physicians, and evidence-based selection of instruments. Patient research partners are involved in each of the projects. The working group will present findings and seek endorsement for the new PsA core domain set, outcome measurement set, and research agenda at the OMERACT meeting in May 2016.

Entities:  

Keywords:  CORE SET; OUTCOME MEASURES; PSORIATIC ARTHRITIS

Mesh：

Year:  2016        PMID： 27134271      PMCID： PMC5235387          DOI： 10.3899/jrheum.160116

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


  24 in total

Review 1.  Clinical outcomes in psoriatic arthritis: A systematic literature review.

Authors:  Penélope Esther Palominos; Cécile Gaujoux-Viala; Bruno Fautrel; Maxime Dougados; Laure Gossec
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-03       Impact factor: 4.794

Review 2.  Enhanced Patient Involvement and the Need to Revise the Core Set - Report from the Psoriatic Arthritis Working Group at OMERACT 2014.

Authors:  William Tillett; Lihi Eder; Niti Goel; Maarten De Wit; Dafna D Gladman; Oliver FitzGerald; Willemina Campbell; Philip S Helliwell; Laure Gossec; Ana-Maria Orbai; Alexis Ogdie; Vibeke Strand; Neil J McHugh; Philip J Mease
Journal:  J Rheumatol       Date:  2015-05-01       Impact factor: 4.666

3.  Reducing survey burden: feasibility and validity of PROMIS measures in multiple sclerosis.

Authors:  Angela Senders; Douglas Hanes; Dennis Bourdette; Ruth Whitham; Lynne Shinto
Journal:  Mult Scler       Date:  2014-01-08       Impact factor: 6.312

4.  Effect of psoriatic arthritis according to the affected categories of the international classification of functioning, disability and health.

Authors:  William J Taylor; Philip J Mease; Adewale Adebajo; Peter J Nash; Marie Feletar; Dafna D Gladman
Journal:  J Rheumatol       Date:  2010-07-01       Impact factor: 4.666

5.  Consensus on a core set of domains for psoriatic arthritis.

Authors:  Dafna D Gladman; Philip J Mease; Vibeke Strand; Paul Healy; Philip S Helliwell; Oliver Fitzgerald; Alice B Gottlieb; Gerald G Krueger; Peter Nash; Christopher T Ritchlin; William Taylor; Ade Adebajo; Jurgen Braun; Alberto Cauli; Sueli Carneiro; Ernst Choy; Ben Dijkmans; Luiz Espinoza; Desiree van der Heijde; Elaine Husni; Ennio Lubrano; Dennis McGonagle; Abrar Qureshi; Enrique R Soriano; Jane Zochling
Journal:  J Rheumatol       Date:  2007-05       Impact factor: 4.666

6.  Patient participation in psoriasis and psoriatic arthritis outcome research: a report from the GRAPPA 2013 Annual Meeting.

Authors:  Maarten de Wit; Willemina Campbell; Oliver FitzGerald; Dafna D Gladman; Phillip S Helliwell; Jana James; Chris Lindsay; Roland MacDonald; Neil J McHugh; Philip J Mease; Ana-Maria Orbai; Penélope Palominos; Andrew Parkinson; William Tillett; Niti Goel
Journal:  J Rheumatol       Date:  2014-06       Impact factor: 4.666

7.  Validation of GAITRite and PROMIS as high-throughput physical function outcome measures following ACL reconstruction.

Authors:  M Owen Papuga; Christopher A Beck; Stephen L Kates; Edward M Schwarz; Michael D Maloney
Journal:  J Orthop Res       Date:  2014-02-14       Impact factor: 3.494

8.  Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist.

Authors:  Caroline B Terwee; Lidwine B Mokkink; Dirk L Knol; Raymond W J G Ostelo; Lex M Bouter; Henrica C W de Vet
Journal:  Qual Life Res       Date:  2011-07-06       Impact factor: 4.147

Review 9.  Patient involvement in outcome measures for psoriatic arthritis.

Authors:  William Tillett; Ade Adebajo; Mel Brooke; Willemina Campbell; Laura C Coates; Oliver FitzGerald; Laure Gossec; Philip Helliwell; Sarah Hewlett; Jana James; Patricia Minnock; Aisling Reast; Dennis O'Sullivan; Maarten de Wit; Neil McHugh
Journal:  Curr Rheumatol Rep       Date:  2014-05       Impact factor: 4.592

10.  Patient participation as an integral part of patient-reported outcomes development ensures the representation of the patient voice: a case study from the field of rheumatology.

Authors:  M P T de Wit; T K Kvien; L Gossec
Journal:  RMD Open       Date:  2015-08-05
View more
  10 in total

1.  Comparative effectiveness of secukinumab and etanercept in biologic-naïve patients with psoriatic arthritis assessed by matching-adjusted indirect comparison.

Authors:  Philip Mease; Ernest Choy; Peter Nash; Chrysostomos Kalyvas; Matthias Hunger; Luminita Pricop; Kunal K Gandhi; Steffen M Jugl; Howard Thom
Journal:  Eur J Rheumatol       Date:  2018-07-01

Review 2.  Incorporating the patient's perspective in outcomes research.

Authors:  Betty Hsiao; Liana Fraenkel
Journal:  Curr Opin Rheumatol       Date:  2017-03       Impact factor: 5.006

3.  Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working Group.

Authors:  Alexis Ogdie; Maarten de Wit; Kristina Callis Duffin; Willemina Campbell; Jeffrey Chau; Laura C Coates; Lihi Eder; Musaab Elmamoun; Oliver FitzGerald; Dafna D Gladman; Niti Goel; Jana James; Umut Kalyoncu; John Latella; Chris Lindsay; Philip J Mease; Denis O'Sullivan; Ingrid Steinkoenig; Vibeke Strand; William Tillett; Ana-Maria Orbai
Journal:  J Rheumatol       Date:  2017-05       Impact factor: 4.666

4.  Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison.

Authors:  Peter Nash; Iain B McInnes; Philip J Mease; Howard Thom; Matthias Hunger; Andreas Karabis; Kunal Gandhi; Shephard Mpofu; Steffen M Jugl
Journal:  Rheumatol Ther       Date:  2018-03-31

Review 5.  Enthesitis: Much More Than Focal Insertion Point Inflammation.

Authors:  Abdulla Watad; Richard J Cuthbert; Howard Amital; Dennis McGonagle
Journal:  Curr Rheumatol Rep       Date:  2018-05-30       Impact factor: 4.592

6.  Change in psoriatic arthritis outcome measures impacts SF-36 physical and mental component scores differently: an observational cohort study.

Authors:  Marie Skougaard; Tanja S Jørgensen; Mia J Jensen; Christine Ballegaard; Jørgen Guldberg-Møller; Alexander Egeberg; Robin Christensen; Peter Benzin; Zara R Stisen; Joseph F Merola; Laura C Coates; Vibeke Strand; Phillip Mease; Lars Erik Kristensen
Journal:  Rheumatol Adv Pract       Date:  2021-11-02

7.  Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016.

Authors:  Ana-Maria Orbai; Maarten de Wit; Philip J Mease; Kristina Callis Duffin; Musaab Elmamoun; William Tillett; Willemina Campbell; Oliver FitzGerald; Dafna D Gladman; Niti Goel; Laure Gossec; Pil Hoejgaard; Ying Ying Leung; Chris Lindsay; Vibeke Strand; Désirée M van der Heijde; Bev Shea; Robin Christensen; Laura Coates; Lihi Eder; Neil McHugh; Umut Kalyoncu; Ingrid Steinkoenig; Alexis Ogdie
Journal:  J Rheumatol       Date:  2017-02-01       Impact factor: 4.666

8.  International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials.

Authors:  Ana-Maria Orbai; Maarten de Wit; Philip Mease; Judy A Shea; Laure Gossec; Ying Ying Leung; William Tillett; Musaab Elmamoun; Kristina Callis Duffin; Willemina Campbell; Robin Christensen; Laura Coates; Emma Dures; Lihi Eder; Oliver FitzGerald; Dafna Gladman; Niti Goel; Suzanne Dolwick Grieb; Sarah Hewlett; Pil Hoejgaard; Umut Kalyoncu; Chris Lindsay; Neil McHugh; Bev Shea; Ingrid Steinkoenig; Vibeke Strand; Alexis Ogdie
Journal:  Ann Rheum Dis       Date:  2016-09-09       Impact factor: 19.103

9.  Burden of Psoriatic Arthritis According to Different Definitions of Disease Activity: Comparing Minimal Disease Activity and the Disease Activity Index for Psoriatic Arthritis.

Authors:  Kim Wervers; Marijn Vis; Ilja Tchetveriko; Andreas H Gerards; Marc R Kok; Cathelijne W Y Appels; Wiebo L van der Graaff; Johannes H L M van Groenendael; Lindy-Anne Korswagen; Josien J Veris-van Dieren; Johanna M W Hazes; Jolanda J Luime
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-12       Impact factor: 4.794

10.  Fatigue numeric rating scale validity, discrimination and responder definition in patients with psoriatic arthritis.

Authors:  Dafna Gladman; Peter Nash; Hitoshi Goto; Julie A Birt; Chen-Yen Lin; Ana-Maria Orbai; Tore K Kvien
Journal:  RMD Open       Date:  2020-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.